SMSPHARMA416.00

SMS Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersINDSWFTLABSOLARADCALUNICHEMLABGUFICBIORPGLIFEHIKALGUJTHEMMcap ₹3,896 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation31.534.339.9
+ Finance Costs22.517.421.8
+ Interest Income-0.2-0.2-0.6
+ Undistributed Profits of Associates0.0-1.00.5
+ Other Non-cash Items-0.0-0.20.1
+ Other — Cash Effects are Investing / Financing-0.0-0.00.0
+ Other Reconciling Items0.20.00.0
Changes in Working Capital
+ Inventories-10.2-51.0-66.5
+ Trade Receivables — Current-87.833.0-12.6
+ Other Financial Assets — Current3.3-6.66.3
+ Other Financial Assets — Non-current-0.1-1.8-0.3
+ Other Current Assets0.59.6-7.6
+ Other Non-current Assets-8.34.9-22.3
+ Trade Payables — Current43.9-37.46.5
+ Other Financial Liabilities — Current2.26.21.3
+ Other Current Liabilities1.9-0.01.2
Cash from Operating Activities
Profit Before Tax (per I/S)66.192.3116.6119.5
+ Total Adjustments (incl. Working Capital)-0.69.2-33.3
Cash from Operations (pre-tax)65.5101.583.3
+ Income Taxes Paid15.419.824.1
Cash from Operating Activities50.181.759.2
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)52.2123.4130.6
+ Disp of Fixed Assets0.10.10.0
+ Interest Received — Investing0.20.20.8
+ Other Inflows / (Outflows) — Investing-0.2-0.3-1.0
Cash from Investing Activities-52.1-123.4-130.8
Cash from Financing Activities
+ Proceeds from Other Equity Instruments28.538.147.6
+ Proceeds from Borrowings45.163.788.4
+ Repayment of Borrowings37.844.134.4
+ Payment of Lease Liabilities1.00.70.0
+ Interest Paid21.817.422.1
+ Dividends Paid2.53.43.5
+ Other Inflows / (Outflows) — Financing20.210.80.0
Cash from Financing Activities30.747.176.0
Net Changes in Cash (pre-FX)28.75.44.5
Net Changes in Cash28.75.44.5
Closing Cash36.0
Reference Items
EBITDA116.6139.0171.3172.9
EBITDA Margin %16.4417.7619.3119.25
Free Cash Flow (CFO − Capex)-2.0-41.7-71.3-71.3
Free Cash Flow to Equity-28.4-39.2
Free Cash Flow per Basic Share-0.22-4.45-7.62-7.62
Cash Flow to Net Income1.011.180.58
Cash Paid for Taxes15.419.824.1
Cash Paid for Interest21.817.422.1
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.